| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/06/2008 | US20080058254 Composition and method for enhancing or promoting the activity of insulin, enhancing skeletal muscle growth, reducing skeletal muscle loss, and increasing the energy supply to skeletal muscle |
| 03/06/2008 | US20080058253 Deoxononadepsipeptides |
| 03/06/2008 | US20080058252 Use of C5A receptor antagonist in the treatment of fibrosis |
| 03/06/2008 | US20080058251 Substituted nonadepsipeptides |
| 03/06/2008 | US20080058250 Using mixture of active drug and phosphate binder; active drugs include hypotensive agents, vitamin d, lipids, calcitrol, potassium salts,anemia therapy or alkalization agent |
| 03/06/2008 | US20080058249 Complexes |
| 03/06/2008 | US20080058248 Toxin Complex Proteins and Genes from Xenorhabdus bovienii |
| 03/06/2008 | US20080058247 Polynucleotides and Polypeptides Encoding Receptors |
| 03/06/2008 | US20080058246 Polymer conjugates of cytokines, chemokines, growth factors, polypeptide hormones and antagonists thereof with preserved receptor-binding activity |
| 03/06/2008 | US20080058245 Cloning nucleic acids coded for therapy |
| 03/06/2008 | US20080057579 Methods and products for manipulating hematopoietic stem cells |
| 03/06/2008 | US20080057565 Method for overexpression of zwitterionic polysaccharides |
| 03/06/2008 | US20080057540 Novel DKR polypeptides |
| 03/06/2008 | US20080057539 Glutamate transporter associated proteins and methods of use thereof |
| 03/06/2008 | US20080057537 Nucleic acid encoding polypeptide involved in cellular entrance of the PRRS virus |
| 03/06/2008 | US20080057517 Methods of regulating cytokine signalling |
| 03/06/2008 | US20080057515 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 03/06/2008 | US20080057510 Human Vascular IBP-Like Growth Factor |
| 03/06/2008 | US20080057509 Defects in Periaxin Associated with Myelinopathies |
| 03/06/2008 | US20080057131 Glycolic acid-lactic acid copolymer matrix incorporated with a peptide drug and a corticosteroid; sustained release for two weeks; improved bioavailability |
| 03/06/2008 | US20080057128 Biodegradable triblock copolymers, synthesis methods therefore, and hydrogels and biomaterials made there from |
| 03/06/2008 | US20080057126 Implant and process for its production |
| 03/06/2008 | US20080057097 Coating comprises one or more cell adhesion polypeptides and a means for temporarily protecting polypeptides from biofouling; coating comprises a bacteriophage, grafted onto polybisphosphonate coating, wherein the bacteriophage displays cell adhesion polypeptides |
| 03/06/2008 | US20080057096 Comprising stent body, first layer applied over stent body comprising a therapeutic substance and second layer applied over first layer comprising a fluoride-containing hydrophilic water insoluble crosslinked resin; biocompatible layer leaches fluoride to provide further therapy to patient |
| 03/06/2008 | US20080057077 Tumour-associated peptides binding to mhc-molecules |
| 03/06/2008 | US20080057076 Novel fibroblast growth factors |
| 03/06/2008 | US20080057072 Antagonists of ci-m6p/igf2r for prevention and treatment of ctgf-mediated ocular disorders |
| 03/06/2008 | US20080057069 Method of increasing trafficking of endothelial progenitor cells to ischemia-damaged tissue |
| 03/06/2008 | US20080057068 SARMS and method of use thereof |
| 03/06/2008 | US20080057065 Phep, an Amino Acid Permease of Staphylococcus Aureus |
| 03/06/2008 | US20080057064 Erbb3 Based Methods and Compositions for Treating Neoplasms |
| 03/06/2008 | US20080057060 Method and system to remove cytokine inhibitor in patients |
| 03/06/2008 | US20080057059 Pharmaceutical Composition Comprising Factor VII Polypeptides and Protein S Inhibitors |
| 03/06/2008 | US20080057058 Uses of il-23 agonists and antagonists; related reagents |
| 03/06/2008 | US20080057052 Compositions and methods for treating cancer |
| 03/06/2008 | US20080057051 Method for fostering bone formation and preservation |
| 03/06/2008 | US20080057050 Intravenous injection of plasminogen non-neurotoxic activators for treating cerebral stroke |
| 03/06/2008 | US20080057049 Cationic latex as a carrier for bioactive ingredients and methods for making and using the same |
| 03/06/2008 | US20080057048 Non-immunognic polyethylene glycol conjugated therapeutic uricase for use in treatment of kidney and inflammatory disorders |
| 03/06/2008 | US20080057038 bacteriophage-drug conjugates, where the bacteriophage displays on its coat a ligand that endows it with specificity towards target cells, used as high-capacity drug delivery systems |
| 03/06/2008 | US20080057037 Treatment of neoplasms with viruses |
| 03/06/2008 | US20080057035 Methods of treating various cancers using melanoma differentiation associated protein-7 |
| 03/06/2008 | US20080057033 Neural Stem Cells and Methods of Generating and Utilizing Same |
| 03/06/2008 | US20080057032 Combination therapy (temozolomide and alpha-ifn) for advanced cancer |
| 03/06/2008 | US20080057031 Antiviral phosphinate compounds |
| 03/06/2008 | US20080057030 comprising administering an effective amount of Interferon-gamma (IFN-gamma) and corticosteroids; treatment of respiratory system disorders |
| 03/06/2008 | US20080057029 Administering cell expressing a cytokine from a recombinant polynucleotide, where the cells has been inactivated to prevent proliferation; a mixture of antigen and genetic engineered allogenic cell |
| 03/06/2008 | US20080057028 Vegf-C or Vegf-D Materials and Methods for Stimulation of Neural Stem cells |
| 03/06/2008 | US20080057027 Methods and devices to regulate stem cell homing |
| 03/06/2008 | US20080057004 Albumin-insulin fusion proteins |
| 03/06/2008 | CA2662172A1 Method for ameliorating pain by modification of nmda receptors through inhibition of src |
| 03/06/2008 | CA2662163A1 Method of treatment of photodermatoses |
| 03/06/2008 | CA2662101A1 Candidates against infection |
| 03/06/2008 | CA2662083A1 Novel drug target of preventing and treating periodontal disease, improving healing of periodontal wounds and promoting oral health |
| 03/06/2008 | CA2662038A1 Method for reducing incidence or rate of development of skin cancers and related conditions |
| 03/06/2008 | CA2662026A1 Compositions and methods for modulating ampa receptor-mediated excitotoxicity |
| 03/06/2008 | CA2661872A1 Process for the purification of fc-fusion proteins |
| 03/06/2008 | CA2661833A1 Sensitization of tumor cells to radiation therapy through the administration of endothelin agonists |
| 03/06/2008 | CA2661668A1 Sunscreen compositions |
| 03/06/2008 | CA2661599A1 Fusion proteins comprising tnf and fibritin trimerization domain |
| 03/06/2008 | CA2661567A1 Microparticles based on an amphiphilic copolymer and on active ingredient(s) with modified release and pharmaceutical formulations containing same |
| 03/06/2008 | CA2661521A1 Pharmaceutical compositions comprising hgh for oral delivery |
| 03/06/2008 | CA2661012A1 Method of treating stroke with thrombolytic agent |
| 03/06/2008 | CA2660732A1 Methods relating to peripheral administration of nogo receptor polypeptides |
| 03/06/2008 | CA2660260A1 Use of modified interleukin-8 proteins |
| 03/05/2008 | EP1895017A2 Use of A33 antigens and JAM-IT |
| 03/05/2008 | EP1895006A1 Interleukin-17 related mammalian cytokines. Polynucleotides encoding them. Uses |
| 03/05/2008 | EP1895005A1 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 03/05/2008 | EP1895002A1 Novel trypsin family serine proteases |
| 03/05/2008 | EP1895001A1 Novel trypsin family serine proteases |
| 03/05/2008 | EP1894944A1 Methods for conversion of interferon isoforms and products thereof |
| 03/05/2008 | EP1894940A1 TNF superfamily fusion proteins |
| 03/05/2008 | EP1894575A1 Therapeutic agent for cancer |
| 03/05/2008 | EP1894574A1 Anti-cancer agent comprising protein c inhibitor |
| 03/05/2008 | EP1894573A2 Methods and compositions for oxygen transport comprising a high oxygen affinity |
| 03/05/2008 | EP1894572A1 Therapeutic agent and/or prophylactic agent for neurogenic pain |
| 03/05/2008 | EP1894571A1 Use of modified interleukin-8 proteins for treating reperfusion injury or transplant rejection |
| 03/05/2008 | EP1894570A2 Methods and compositions for the treatment of peripheral artery disease |
| 03/05/2008 | EP1894567A1 Concomitant pharmaceutical agents and use thereof |
| 03/05/2008 | EP1893953A2 Oral drug delivery system and methods of use thereof |
| 03/05/2008 | EP1893643A1 Compositions and methods for preventing or treating hiv infection |
| 03/05/2008 | EP1893634A2 Pyrimidine derivatives and their use as p2y12 receptor antagonists |
| 03/05/2008 | EP1893633A2 Angiotensin i - converting enzyme (ace) inhibitors |
| 03/05/2008 | EP1893239A2 Transglutaminase mediated conjugation of growth hormone |
| 03/05/2008 | EP1893231A2 Use of plasmin for preventing of reducing the rate of the progression of non-proliferative diabetic retinopathy and the treatment of other ocular conditions |
| 03/05/2008 | EP1893230A2 Use of modified factor vii for treating bleeding |
| 03/05/2008 | EP1893228A2 Chimericpoly peptides and the therapeutic use thereof against a flaviviridae infection |
| 03/05/2008 | EP1893227A2 Methods for treatment or prophylaxis of atherosclerosis and reperfusion injury |
| 03/05/2008 | EP1893226A1 Cyclosporins to treat alzheimer's disease |
| 03/05/2008 | EP1893224A1 Use of plant cell membrane for the for the treatment of obesity |
| 03/05/2008 | EP1893187A2 Improved antimicrobial peroxidase compositions |
| 03/05/2008 | EP1893186A2 Improved treatment for anemia using a hif-alpha stabilising agent |
| 03/05/2008 | EP1893185A2 Use of urokinase inhibitors for the treatment and/or prevention of neuropathological diseases |
| 03/05/2008 | EP1661913B1 Bioactive peptides derived from the proteins of egg white by means of enzymatic hydrolysis |
| 03/05/2008 | EP1644382B1 Cross-linked glycopeptide-cephalosporin antibiotics |
| 03/05/2008 | EP1613343A4 Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same |
| 03/05/2008 | EP1611173B1 Polymeric modifiers and pharmaceutical compositions |
| 03/05/2008 | EP1575656A4 Insulin delivery system with sensor |
| 03/05/2008 | EP1564236B1 Polyalkylen glycol derivative |
| 03/05/2008 | EP1383733B1 Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds |